HUE053347T2 - Glikopeptid-készítmények - Google Patents

Glikopeptid-készítmények

Info

Publication number: HUE053347T2
Authority: HU; Hungary
Prior art keywords: glycopeptide; preparations; glycopeptide preparations
Prior art date: 2014-11-06

Application number

HUE19174849A

Other languages

English (en)

Hungarian (hu)

Inventor

Ivona Jasprica

Sabina Keser

Katarina Pindric

Original Assignee

Xellia Pharmaceuticals Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-11-06

Filing date

2015-11-06

Publication date

2021-06-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54478023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE053347(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-11-06 Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps

2021-06-28 Publication of HUE053347T2 publication Critical patent/HUE053347T2/hu

Links

DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 title 1
102000002068 Glycopeptides Human genes 0.000 title 1
108010015899 Glycopeptides Proteins 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

HUE19174849A 2014-11-06 2015-11-06 Glikopeptid-készítmények HUE053347T2 (hu)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201462076400P	2014-11-06	2014-11-06
US201562168749P	2015-05-30	2015-05-30

Publications (1)

Publication Number	Publication Date
HUE053347T2 true HUE053347T2 (hu)	2021-06-28

Family

ID=54478023

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HUE19174849A HUE053347T2 (hu)	2014-11-06	2015-11-06	Glikopeptid-készítmények
HUE15791287A HUE049857T2 (hu)	2014-11-06	2015-11-06	Glikopeptid-készítmények

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
HUE15791287A HUE049857T2 (hu)	2014-11-06	2015-11-06	Glikopeptid-készítmények

Country Status (29)

Country	Link
US (8)	US10188697B2 (2)
EP (4)	EP3834837A1 (2)
JP (2)	JP6797795B2 (2)
KR (2)	KR102763211B1 (2)
CN (1)	CN107073072B (2)
AU (1)	AU2015341763B2 (2)
BR (1)	BR112017009405B1 (2)
CL (1)	CL2017001139A1 (2)
CO (1)	CO2017005391A2 (2)
CR (1)	CR20170234A (2)
CY (2)	CY1122960T1 (2)
DK (2)	DK3215173T3 (2)
EA (1)	EA035368B1 (2)
ES (2)	ES2769849T3 (2)
HR (2)	HRP20200101T1 (2)
HU (2)	HUE053347T2 (2)
IL (1)	IL252120B (2)
MX (1)	MX387229B (2)
NZ (1)	NZ731955A (2)
PH (1)	PH12017500720A1 (2)
PL (2)	PL3542812T3 (2)
PT (2)	PT3542812T (2)
RS (2)	RS59851B1 (2)
SA (1)	SA517381446B1 (2)
SG (1)	SG11201703568WA (2)
SI (2)	SI3542812T1 (2)
TN (1)	TN2017000182A1 (2)
WO (1)	WO2016071495A1 (2)
ZA (1)	ZA201702767B (2)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE053347T2 (hu)	2014-11-06	2021-06-28	Xellia Pharmaceuticals Aps	Glikopeptid-készítmények
US20190000789A1 (en) *	2015-12-24	2019-01-03	Universiteit Leiden	Composition and method for treating infections caused by vancomycin-resistant infectious agents in a subject
KR20190005940A (ko) *	2016-05-09	2019-01-16	셀리아 파마슈티칼즈 에이피에스	안정화된 글리코펩티드 항생제 제형
RU2019119405A (ru) *	2016-11-23	2020-12-25	Гуфик Байосайенсиз Лимитед	Лиофилизированные фармацевтические композиции далбаванцина
JP7118412B2 (ja) *	2017-07-31	2022-08-16	東洋製薬化成株式会社	バンコマイシン懸濁液充填カプセル製剤
CN109725101B (zh) *	2017-10-31	2021-11-19	正大天晴药业集团股份有限公司	盐酸特拉万星原料中有关物质的检测方法
CN109078001B (zh) *	2018-09-21	2021-05-07	深圳浦瑞健康科技有限公司	一种万古霉素纳米脂质体组合物及其制备方法
US20220184173A1 (en)	2019-03-08	2022-06-16	Emphascience, Inc.	Stable pharmaceutical formulations of peptide and protein drugs
WO2022031830A1 (en) *	2020-08-04	2022-02-10	Harrow Ip Llc	Antibacterial compositions and methods for fabricating thereof
US11433115B2 (en) *	2020-10-30	2022-09-06	Somerset Therapeutics, Llc	Glycopeptide antibiotics liquid formulations and methods and uses thereof
EP4014965A1 (en)	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution
EP4014969A1 (en) *	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution
WO2022234036A1 (en) *	2021-05-07	2022-11-10	Xellia Pharmaceuticals Aps	Oral liquid vancomycin formulations
CN115804832A (zh) *	2021-09-14	2023-03-17	海南普利制药股份有限公司	一种万古霉素水溶液组合物
WO2023171588A1 (ja) *	2022-03-08	2023-09-14	国立大学法人大阪大学	抗菌薬を含有するｐｌｇａ製剤
GB202207345D0 (en)	2022-05-19	2022-07-06	Arecor Ltd	Novel composition
GB202207344D0 (en)	2022-05-19	2022-07-06	Arecor Ltd	Novel composition
EP4601615A1 (en)	2022-10-12	2025-08-20	Hikma Pharmaceuticals USA Inc.	Liquid dalbavancin composition
AU2023359653A1 (en) *	2022-10-12	2025-05-29	Hikma Pharmaceuticals Usa Inc.	Liquid dalbavancin composition
WO2025006267A1 (en) *	2023-06-26	2025-01-02	Venn Biosciences Corporation	Peptide biomarkers for diagnosing primary sclerosing cholangitis or primary biliary cholangitis
GB202405997D0 (en)	2024-04-29	2024-06-12	Arecor Ltd	Novel compositions
GB202405996D0 (en)	2024-04-29	2024-06-12	Arecor Ltd	Novel compositions

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4670258A (en)	1984-02-10	1987-06-02	Vanderbilt University	Storable prepackaged aqueous solutions of vancomycin
MY128335A (en)	1994-01-28	2007-01-31	Lilly Co Eli	Glycopeptide antibiotic derivatives
WO1997019690A1 (en)	1995-12-01	1997-06-05	Eli Lilly And Company	Stable vancomycin hydrochloride solutions
JPH1180021A (ja)	1997-09-02	1999-03-23	Kayaku:Kk	バンコマイシン注射剤
US6800608B2 (en)	2001-06-22	2004-10-05	Beckman Coulter, Inc.	Homogeneous assay of vancomycin using a stable particle-vancomycin conjugate, a novel rate enhancer, and a novel dose response modulator
JP2005521712A (ja) *	2002-03-26	2005-07-21	アリゾナボードオブリージェンツオンビハーフオブザユニバーシティーオブアリゾナ	弱塩基の可溶化
GB0212622D0 (en) *	2002-05-31	2002-07-10	Natural Technologies Group Ltd	Bacterial transforming agent
US20050084490A1 (en)	2002-07-09	2005-04-21	Point Therapeutics, Inc.	Boroproline compound combination therapy
CN1826129A (zh) *	2002-07-09	2006-08-30	尖端医疗有限公司	与异亮氨酸硼脯氨酸化合物相关的方法和组合物
AU2003299561A1 (en)	2002-11-18	2004-06-15	Vicuron Pharmaceuticals Inc.	Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
EP1848413B1 (en)	2005-02-14	2014-04-09	Venus Remedies Limited	Parenteral combination therapy for infective conditions with drug resistant bacterium
CN1857716A (zh) *	2006-03-14	2006-11-08	浙江大学	注射用盐酸万古霉素及其制备方法
JP2008201778A (ja) *	2007-01-25	2008-09-04	Mochida Pharmaceut Co Ltd	バンコマイシン液状製剤
EP2231191A2 (en) *	2007-12-11	2010-09-29	ConjuChem Biotechnologies Inc.	Formulation of insulinotropic peptide conjugates
JP2011080021A (ja)	2009-10-09	2011-04-21	Bridgestone Corp	熱可塑性エラストマー組成物及びその成形体
EP2709646A4 (en) *	2011-05-19	2015-05-13	Savara Inc	DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS
US20150182667A1 (en)	2012-08-08	2015-07-02	Vanderbilt University	Composition with Biofilm Dispersal Agents
RU2018135921A (ru)	2012-11-29	2019-02-05	Инсмед Инкорпорейтед	Стабилизированные составы ванкомицина
CN104043104B (zh)	2013-03-15	2018-07-10	浙江创新生物有限公司	含盐酸万古霉素的喷雾干粉及其工业化制备方法
WO2014194296A1 (en) *	2013-05-30	2014-12-04	Scidose, Llc	Formulations of vancomycin
AU2015229069A1 (en) *	2014-03-14	2016-11-03	CutisPharma,Inc.	Composition and method for vancomycin oral liquid
HUE053347T2 (hu)	2014-11-06	2021-06-28	Xellia Pharmaceuticals Aps	Glikopeptid-készítmények
KR20190005940A (ko)	2016-05-09	2019-01-16	셀리아 파마슈티칼즈 에이피에스	안정화된 글리코펩티드 항생제 제형
US11433115B2 (en)	2020-10-30	2022-09-06	Somerset Therapeutics, Llc	Glycopeptide antibiotics liquid formulations and methods and uses thereof
EP4014965A1 (en)	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution
EP4014969A1 (en)	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution

2015
- 2015-11-06 HU HUE19174849A patent/HUE053347T2/hu unknown
- 2015-11-06 CR CR20170234A patent/CR20170234A/es unknown
- 2015-11-06 PT PT191748490T patent/PT3542812T/pt unknown
- 2015-11-06 EP EP20215453.0A patent/EP3834837A1/en not_active Withdrawn
- 2015-11-06 PL PL19174849T patent/PL3542812T3/pl unknown
- 2015-11-06 DK DK15791287.4T patent/DK3215173T3/da active
- 2015-11-06 PL PL15791287T patent/PL3215173T3/pl unknown
- 2015-11-06 HR HRP20200101TT patent/HRP20200101T1/hr unknown
- 2015-11-06 KR KR1020237020985A patent/KR102763211B1/ko active Active
- 2015-11-06 HU HUE15791287A patent/HUE049857T2/hu unknown
- 2015-11-06 EP EP15791287.4A patent/EP3215173B8/en not_active Revoked
- 2015-11-06 EP EP22203229.4A patent/EP4147710A1/en active Pending
- 2015-11-06 BR BR112017009405-3A patent/BR112017009405B1/pt active IP Right Grant
- 2015-11-06 WO PCT/EP2015/075918 patent/WO2016071495A1/en not_active Ceased
- 2015-11-06 TN TN2017000182A patent/TN2017000182A1/en unknown
- 2015-11-06 JP JP2017523438A patent/JP6797795B2/ja active Active
- 2015-11-06 EA EA201790997A patent/EA035368B1/ru unknown
- 2015-11-06 AU AU2015341763A patent/AU2015341763B2/en active Active
- 2015-11-06 RS RS20200080A patent/RS59851B1/sr unknown
- 2015-11-06 SI SI201531539T patent/SI3542812T1/sl unknown
- 2015-11-06 PT PT157912874T patent/PT3215173T/pt unknown
- 2015-11-06 ES ES15791287T patent/ES2769849T3/es active Active
- 2015-11-06 CN CN201580060330.2A patent/CN107073072B/zh active Active
- 2015-11-06 NZ NZ731955A patent/NZ731955A/en unknown
- 2015-11-06 SG SG11201703568WA patent/SG11201703568WA/en unknown
- 2015-11-06 EP EP19174849.0A patent/EP3542812B1/en active Active
- 2015-11-06 SI SI201531067T patent/SI3215173T1/sl unknown
- 2015-11-06 US US15/524,653 patent/US10188697B2/en active Active
- 2015-11-06 DK DK19174849.0T patent/DK3542812T3/da active
- 2015-11-06 RS RS20210108A patent/RS61418B1/sr unknown
- 2015-11-06 ES ES19174849T patent/ES2852550T3/es active Active
- 2015-11-06 KR KR1020177015221A patent/KR102603756B1/ko active Active
- 2015-11-06 MX MX2017005749A patent/MX387229B/es unknown
2017
- 2017-04-18 PH PH12017500720A patent/PH12017500720A1/en unknown
- 2017-04-19 ZA ZA2017/02767A patent/ZA201702767B/en unknown
- 2017-05-01 SA SA517381446A patent/SA517381446B1/ar unknown
- 2017-05-04 IL IL252120A patent/IL252120B/en active IP Right Grant
- 2017-05-05 CL CL2017001139A patent/CL2017001139A1/es unknown
- 2017-05-26 CO CONC2017/0005391A patent/CO2017005391A2/es unknown
- 2017-11-30 US US15/827,719 patent/US10039804B2/en active Active
2018
- 2018-12-11 US US16/216,446 patent/US10849956B2/en active Active
2019
- 2019-11-07 US US16/677,057 patent/US11000567B2/en active Active
2020
- 2020-03-20 CY CY20201100266T patent/CY1122960T1/el unknown
- 2020-07-20 JP JP2020123671A patent/JP7032488B2/ja active Active
2021
- 2021-03-01 HR HRP20210342TT patent/HRP20210342T8/hr unknown
- 2021-03-29 US US17/215,675 patent/US11628200B2/en active Active
- 2021-04-09 CY CY20211100307T patent/CY1124011T1/el unknown
2022
- 2022-07-08 US US17/860,642 patent/US11517609B2/en active Active
2023
- 2023-01-06 US US18/151,155 patent/US12161690B2/en active Active
2024
- 2024-10-30 US US18/932,117 patent/US20250288640A1/en active Pending

Also Published As

Publication number	Publication date
US20250288640A1 (en)	2025-09-18
AU2015341763A1 (en)	2017-06-08
IL252120A0 (en)	2017-07-31
EP3215173B8 (en)	2020-03-11
ES2852550T3 (es)	2021-09-13
US11517609B2 (en)	2022-12-06
RS61418B1 (sr)	2021-03-31
DK3542812T3 (da)	2021-04-12
MX2017005749A (es)	2018-01-11
CA2964524A1 (en)	2016-05-12
AU2015341763B2 (en)	2019-01-17
HRP20200101T1 (hr)	2020-04-03
EA201790997A1 (ru)	2017-09-29
NZ731955A (en)	2023-07-28
MX387229B (es)	2025-03-04
EP3542812B1 (en)	2021-01-13
BR112017009405B1 (pt)	2024-02-06
SA517381446B1 (ar)	2020-09-21
KR102763211B1 (ko)	2025-02-04
US20180133286A1 (en)	2018-05-17
JP6797795B2 (ja)	2020-12-09
RS59851B1 (sr)	2020-02-28
EP3215173B1 (en)	2020-01-01
US10039804B2 (en)	2018-08-07
JP2020183424A (ja)	2020-11-12
HRP20210342T1 (hr)	2021-04-30
SG11201703568WA (en)	2017-05-30
EA035368B1 (ru)	2020-06-03
ZA201702767B (en)	2018-12-19
EP4147710A1 (en)	2023-03-15
ES2769849T3 (es)	2020-06-29
HUE049857T2 (hu)	2020-10-28
PT3215173T (pt)	2020-04-03
CN107073072B (zh)	2021-06-18
CN107073072A (zh)	2017-08-18
IL252120B (en)	2020-07-30
EP3542812A1 (en)	2019-09-25
CL2017001139A1 (es)	2017-12-01
CR20170234A (es)	2018-01-15
US20230158101A1 (en)	2023-05-25
US11628200B2 (en)	2023-04-18
JP7032488B2 (ja)	2022-03-08
WO2016071495A1 (en)	2016-05-12
SI3542812T1 (sl)	2021-04-30
PH12017500720A1 (en)	2017-10-09
CO2017005391A2 (es)	2017-10-31
EP3215173A1 (en)	2017-09-13
US20190160142A1 (en)	2019-05-30
US12161690B2 (en)	2024-12-10
HRP20210342T8 (hr)	2022-01-21
CY1124011T1 (el)	2022-05-27
TN2017000182A1 (en)	2018-10-19
KR20230096142A (ko)	2023-06-29
US20200069768A1 (en)	2020-03-05
SI3215173T1 (sl)	2020-03-31
US11000567B2 (en)	2021-05-11
US20210220433A1 (en)	2021-07-22
EP3834837A1 (en)	2021-06-16
KR20170078830A (ko)	2017-07-07
US20220354927A1 (en)	2022-11-10
KR102603756B1 (ko)	2023-11-16
US20170348385A1 (en)	2017-12-07
PT3542812T (pt)	2021-04-20
US10849956B2 (en)	2020-12-01
US10188697B2 (en)	2019-01-29
CY1122960T1 (el)	2021-10-29
PL3215173T3 (pl)	2020-05-18
JP2017533218A (ja)	2017-11-09
DK3215173T3 (da)	2020-03-23
PL3542812T3 (pl)	2021-07-12
BR112017009405A2 (pt)	2018-01-02

Publication	Publication Date	Title
FIC20230006I1 (fi)	2023-02-06	Vutrisiraani
HUE053347T2 (hu)	2021-06-28	Glikopeptid-készítmények
IL254516A0 (en)	2017-11-30	Proteins specific for cd137
DK3393510T3 (da)	2023-03-13	Zikavirusvaccine
IL249313A0 (en)	2017-02-28	Improved t cell compositions
HUE058288T2 (hu)	2022-07-28	Pridopidin módosított hatóanyag-leadású készítményei
DK3094351T3 (da)	2022-02-21	Immunmodulatoriske midler
IL233902B (en)	2020-07-30	Propulsion system
LT3298027T (lt)	2021-08-10	Antihelmintiniai depsipeptido junginiai
HUE045024T2 (hu)	2019-12-30	Poliamid készítmények
EP3340850A4 (en)	2019-04-17	VACUUM CLEANER
DK3702450T3 (da)	2024-07-15	Protein
EP3354177A4 (en)	2019-04-24	VACUUM CLEANER
HRP20182029T1 (hr)	2019-02-08	Uti-fuzijski proteini
HUE053624T2 (hu)	2021-07-28	Ciklosporint tartalmazó készítmények
EP3900838C0 (en)	2024-11-06	VACUUM INSTALLATION
DK3154689T3 (da)	2021-04-26	Komplekser
DK3448879T3 (da)	2025-04-07	Claudin-6 peptider
DE112015006486A5 (de)	2018-01-04	Inkubationsrinne
DK3099793T3 (da)	2020-03-16	Protein
DK3154945T3 (da)	2021-06-28	Komplekser
HUE054584T2 (hu)	2021-09-28	Maropitant készítmény
DE102015206660A8 (de)	2016-12-08	Plattenaufteilanlage
HUE066069T2 (hu)	2024-07-28	Mikafungin készítmények
DE112015005906A5 (de)	2017-11-02	Gurtschlossbringer